Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
PharmNovo logo — Innovation in pain relief

PharmNovo

Innovation in pain relief

Founded 2008 Sweden Sweden 10 employees Venture round Total: $115.69M Health Care, Pharmaceutical

General Information

Company Name PharmNovo
Founded Year 2008
Location Sweden Sweden
Founders / Decision Makers
Team member Team member
Employees 10
Industries Health Care, Pharmaceutical
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with PharmNovo. To contact PharmNovo, visit pharmnovo.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does PharmNovo compare?

A PDF of PharmNovo and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting PharmNovo soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About PharmNovo

PharmNovo is a clinical-stage pharmaceutical company founded in 2008, with the slogan "Innovation in pain relief." The company is focused on addressing the lack of effective treatments for neuropathic pain. Their drug candidate, PN6047, has shown promising results in reducing neuropathic pain in animal models. Additionally, results from the Phase I trial demonstrated its safety and tolerability, with no serious adverse events reported. A significant investment of kr6.00M in a Series A round was secured by PharmNovo on 15 July 2022, with Sciety being the lead investor. This investment positions the company to advance its lead product, PN6047, to the pivotal Phase II stage. PharmNovo operates within the Health Care and Pharmaceutical industries, with its headquarters located in Sweden. The company's innovative approach to pain management, along with the support from notable investors, positions PharmNovo as a key player in addressing the unmet need for effective neuropathic pain treatments.

Business keywords: Pharmaceuticals, Pain Relief, Chronic Pain Therapy, Delta Opioid Receptor Agonists, Drug Development, Medical Innovation, Toxicology Studies, Clinical Trials, Investment, Startup, Innovation, Opioid Crisis

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round €15.00M 1
EIC Accelerator
16 Jul 2024
Grant €2.50M 1
EIC Accelerator
16 Jul 2024
Venture Round kr23.10M 3
Almi Invest
Almi Invest, Sciety +1
26 Sep 2023
Series A kr6.00M 1
Sciety
15 Jul 2022
Venture Round kr67.00M 4
Almi Invest
Almi Invest, Sciety +2
03 Jun 2022
Series A €2.09M 1
Sciety
01 Sep 2020

PharmNovo Alternatives & Competitors

View All Alternatives
PharmNovo vs
Sen-Jam Pharmaceutical
Sen-Jam Pharmaceutical

We’re changing the way the world treats inflammation and the way the pharma industry treats humanity

Seed
12 employees
Biotechnology, Health Care
PharmNovo vs
Vitalis Pharma
Vitalis Pharma United States

Aiming to Improve Patients'​ Lives in Multiple Sclerosis, Post-op Pain (Non-opioid), and Dyslipidemi...

2 employees
Health Care, Manufacturing
PharmNovo vs
HealthMatch
HealthMatch Australia

Connecting People To Revolutionary Drugs And Potential Cures

Series C
24 employees
Biotechnology, Health Care
View all alternatives

FAQ About PharmNovo

Innovation in pain relief
PharmNovo was founded in 2008.
PharmNovo is headquartered in Sweden.
PharmNovo operates in Health Care and Pharmaceutical. Its work centres on Pharmaceuticals, Pain Relief, Chronic Pain Therapy and Delta Opioid Receptor Agonists.
PharmNovo has approximately 10 employees.
PharmNovo has completed 6 funding rounds, raising a total of $115.69M. The latest funding stage is Venture round.
Top alternatives and competitors to PharmNovo include Sen-Jam Pharmaceutical, Vitalis Pharma, HealthMatch , VaxCell Biotherapeutics Co., Ltd., Latigo Biotherapeutics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
PharmNovo and Sen-Jam Pharmaceutical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for PharmNovo, https://bouncewatch.com/company/pharmnovo, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout